根治性前列腺切除术后预测生化复发和前列腺癌特异性死亡:在筛查发现与临床发现前列腺癌患者队列中六种预测模型的比较
该研究回顾性评估了795例筛查发现前列腺癌(S-PCa)和1123例临床发现前列腺癌(C-PCa)患者,外部验证三种预测生化复发(BCR)和三种预测前列腺癌特异性死亡(PCSM)的模型。BCR模型在两组均有良好区分度且S-PCa组更优,但PCSM模型校准差,不适用于该荷兰队列的两种场景。
要点
- BCR模型在S-PCa组AUC 0.77-0.84,在C-PCa组AUC 0.75-0.79。
- PCSM模型在S-PCa组AUC 0.60-0.77,在C-PCa组AUC 0.51-0.68。
- BCR风险通常被高估,而PCSM风险通常被低估。
核心结论
- BCR预测模型在S-PCa和C-PCa患者中均显示良好区分度和合理校准,且在S-PCa患者中区分度更优。
- PCSM预测模型由于校准严重偏差,不适用于该荷兰队列的两种场景,使用这些模型沟通未来风险时需谨慎。
研究设计与样本
- 回顾性评估795例来自鹿特丹欧洲前列腺癌筛查随机研究(ERSPC)的S-PCa患者和1123例初治接受根治性前列腺切除术(RP)的C-PCa患者。
- 比较三种预测BCR和三种预测PCSM的模型,通过受试者工作特征曲线下面积(AUC)评估区分度,并用校准图进行图形化校准评估。
主要发现
- S-PCa组中位随访10.4(IQR 6.8-14.3)年,C-PCa组中位随访8.8(IQR 4.8-12.9)年。
- S-PCa组123例(15%)发生BCR,其中24例(20%)死于前列腺癌,29例(23%)死于其他原因。
- C-PCa组389例(35%)发生BCR,其中68例(17%)死于前列腺癌,105例(27%)死于其他原因。
- BCR模型AUC在S-PCa组为0.77-0.84,在C-PCa组为0.75-0.79;PCSM模型AUC在S-PCa组为0.60-0.77,在C-PCa组为0.51-0.68。
- BCR风险通常被高估,而PCSM风险通常被低估。
关键数值与推荐
- BCR模型在S-PCa组AUC 0.77-0.84,在C-PCa组AUC 0.75-0.79。
- PCSM模型在S-PCa组AUC 0.60-0.77,在C-PCa组AUC 0.51-0.68。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To perform a comparison and external validation of three models predicting biochemical recurrence (BCR) and three models predicting prostate cancer (PCa)-specific mortality (PCSM) in a screening setting, i.e. patients with screening-detected PCa (S-PCa) and in those with clinically detected PCa (C-PCa). SUBJECTS AND METHODS: We retrospectively evaluated 795 men with S-PCa, from the European Randomized Study of Screening for Prostate Cancer, Rotterdam, and 1123 men with C-PCa initially treated with RP. The discriminative ability of the models was assessed according to the area under the curve (AUC) of the receiver-operating characteristic, and calibration was assessed graphically using calibration plots. RESULTS: The median (interquartile range [IQR]) follow-up for the S-PCa group was 10.4 (6.8-14.3) years and for the C-PCa group it was 8.8 (4.8-12.9) years. A total of 123 men with S-PCa (15%) and 389 men with C-PCa (35%) experienced BCR. Of the men with S-PCa and BCR, 24 (20%) died from PCa and 29 (23%) died from other causes. Of the men with C-PCa and BCR, 68 (17%) died from PCa and 105 (27%) died from other causes. The discrimination of the models predicting BCR or PCSM was higher for men with S-PCa (AUC: BCR 0.77-0.84, PCSM 0.60-0.77) than for the men with C-PCa (AUC: BCR 0.75-0.79, PCSM 0.51-0.68) as a result of the similar patient characteristics of the men with S-PCa in the present study and those of the cohorts used to develop these models. The risk of BCR was typically overestimated, while the risk of PCSM was typically underestimated. CONCLUSION: Prediction models for BCR showed good discrimination and reasonable calibration for both men with S-PCa and men with C-PCa, and even better discrimination for men with S-PCa. For PCSM, the evaluated models are not applicable in both settings of this Dutch cohort as a result of substantial miscalibration. This warrants caution when using these models to communicate future risks in other clinical settings.
引用
- Remmers S, Verbeek JFM, Nieboer D, et al. Predicting biochemical recurrence and prostate cancer-specific mortality after radical prostatectomy: comparison of six prediction models in a cohort of patients with screening- and clinically detected prostate cancer. BJU Int. 2019. PMID: 31055875. doi:10.1111/bju.14790
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。